Evidence map›Paper›PMID 19205872›Full record

ArticleBreast cancer research and treatment2010

Regulation of alphaB-crystallin gene expression by the transcription factor Ets1 in breast cancer.

Joshua D Bosman, Fruma Yehiely, Joseph R Evans, Vincent L Cryns

Open access · greenAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joshua D BosmanCell Death Regulation Laboratory, Departments of Medicine and Cell and Molecular Biology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Fruma Yehiely
Joseph R Evans
Vincent L Cryns
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Funding

CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
Role of alphaB-Crystallin in Cancer Cell DeathR01CA097198 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CRYNS, VINCENT L. · 2003 to 2007
$1.0M
alphaBeta-crystallin: A Novel Biomarker in Breast CancerR21CA125181 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CRYNS, VINCENT L. · 2007 to 2008
$332k
NCI NIH HHS R01 CA097198NCI NIH HHS R01CA097198NCI NIH HHS R21 CA125181NCI NIH HHS R21CA125181NIGMS NIH HHS T32 GM008061NIGMS NIH HHS T32GM08061
6 · The paper itself

Abstract

Recent studies indicate that the small heat shock protein alphaB-crystallin is expressed in poor prognosis basal-like breast tumors and likely contributes to their aggressive phenotype. However, the mechanisms underlying the deregulated expression of alphaB-crystallin in basal-like tumors are poorly understood. Using a bioinformatics approach, we identified a putative DNA binding motif in the human alphaB-crystallin promoter for the proto-oncogene Ets1, a member of the ETS transcription factor family that bind to DNA at palindromic ETS-binding sites (EBS). Here we demonstrate that ectopic expression of Ets1 activates the alphaB-crystallin promoter by an EBS-dependent mechanism and increases alphaB-crystallin protein levels, while silencing Ets1 reduces alphaB-crystallin promoter activity and protein levels. Chromatin immunoprecipitation analyses showed that endogenous Ets1 binds to the alphaB-crystallin promoter in basal-like breast cancer cells in vivo. Interrogation of publically available gene expression data revealed that Ets1 is expressed in human basal-like breast tumors and is associated with poor survival. Collectively, our results point to a previously unrecognized link between the oncogenic transcription factor Ets1 and alphaB-crystallin in basal-like breast cancer.

Indexed as

Gene Expression Regulation, Neoplasticalpha-Crystallin B ChainAnimalsBase SequenceBreast NeoplasmsCell Line, TumorChromatin ImmunoprecipitationComputational BiologyFemaleGene SilencingHumansMolecular ChaperonesMolecular Sequence DataPromoter Regions, GeneticProto-Oncogene MasProto-Oncogene Protein c-ets-1alpha-Crystallin B ChainETS1 protein, humanMAS1 protein, humanMolecular ChaperonesProto-Oncogene MasProto-Oncogene Protein c-ets-1

Identifiers

PMID19205872
PMCPMC2791186
OpenAlexW2013575559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.